Honest Company, Inc. HNST
We take great care to ensure that the data presented and summarized in this overview for Honest Company, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HNST
View all-
Institutional Venture Management Xiii, LLC Menlo Park, CA10.5MShares$28.8 Million24.36% of portfolio
-
Portolan Capital Management, LLC Boston, MA7.49MShares$20.6 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$7.84 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.54MShares$6.99 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.52MShares$6.94 Million0.13% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.22MShares$6.1 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY1.68MShares$4.61 Million0.0% of portfolio
-
Marshall Wace, LLP London, X01.67MShares$4.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.06MShares$2.91 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X01.04MShares$2.87 Million0.01% of portfolio
Latest Institutional Activity in HNST
Top Purchases
Top Sells
About HNST
The Honest Company, Inc. manufactures and sells diapers and wipes, skin and personal care, and household and wellness products. The company also offers baby clothing and nursery bedding products. It sells its products through digital and retail sales channels, such as its website and third-party ecommerce sites, as well as brick and mortar retailers. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Insider Transactions at HNST
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 22
2024
|
James D White Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+13.77%
|
-
|
May 22
2024
|
Susan Gentile Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+20.22%
|
-
|
May 22
2024
|
Jack Hartung Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+15.71%
|
-
|
May 22
2024
|
Andrea Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+21.2%
|
-
|
May 22
2024
|
Jessica Warren Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+4.92%
|
-
|
May 22
2024
|
Honest Company, Inc. Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+21.2%
|
-
|
May 22
2024
|
Alissa Hsu Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+21.2%
|
-
|
May 22
2024
|
Katie J Bayne Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,569
+16.92%
|
-
|
May 21
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
8,583
-1.61%
|
$17,166
$2.77 P/Share
|
May 21
2024
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
43,317
-1.48%
|
$86,634
$2.77 P/Share
|
May 21
2024
|
Thomas Sternweis SVP, Enterprise Dev. & Strat. |
SELL
Open market or private sale
|
Direct |
10,047
-4.06%
|
$20,094
$2.77 P/Share
|
May 21
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
7,283
-1.7%
|
$14,566
$2.77 P/Share
|
May 21
2024
|
Katherine Barton Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
67,930
-6.79%
|
$135,860
$2.77 P/Share
|
Apr 19
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
253,815
-18.62%
|
$507,630
$2.99 P/Share
|
Apr 18
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
265,820
-16.32%
|
$797,460
$3.06 P/Share
|
Apr 17
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
276,113
-14.49%
|
$828,339
$3.07 P/Share
|
Mar 18
2024
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
209,160
-6.67%
|
$836,640
$4.16 P/Share
|
Mar 07
2024
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
21,152
-3.81%
|
$63,456
$3.24 P/Share
|
Mar 07
2024
|
Jessica Warren Director |
SELL
Open market or private sale
|
Direct |
23,324
-1.21%
|
$69,972
$3.24 P/Share
|
Mar 07
2024
|
Stephen Winchell EVP, Operations and R&D |
SELL
Open market or private sale
|
Direct |
19,665
-4.38%
|
$58,995
$3.24 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 4.93M shares |
---|---|
Open market or private purchase | 114K shares |
Open market or private sale | 2.48M shares |
---|---|
Other acquisition or disposition | 57K shares |